You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Dose modification and dose intensity during treatment with pirfenidone: analysis of pooled data from three multinational phase III trials

Article metrics

Article menu

Download PDFPDF

XML
Interstitial lung disease
Dose modification and dose intensity during treatment with pirfenidone: analysis of pooled data from three multinational phase III trials

 

Online download statistics by month:

Online download statistics by month: August 2018 to March 2024

AbstractFullPdf
Aug 2018471468170
Sep 201838938799
Oct 201811211248
Nov 201815815343
Dec 2018828234
Jan 2019969432
Feb 2019656329
Mar 201912412340
Apr 2019918520
May 201913212529
Jun 2019817424
Jul 2019868431
Aug 2019807915
Sep 2019898825
Oct 2019959233
Nov 2019939127
Dec 2019858546
Jan 2020757212
Feb 2020888518
Mar 2020686811
Apr 2020444310
May 2020444216
Jun 2020545315
Jul 2020696613
Aug 2020626211
Sep 202010910319
Oct 2020666317
Nov 2020736823
Dec 2020949215
Jan 2021858220
Feb 2021555214
Mar 2021737212
Apr 2021797720
May 2021757117
Jun 2021858224
Jul 2021484510
Aug 2021464616
Sep 2021757512
Oct 2021969442
Nov 2021221818
Dec 2021292417
Jan 202221208
Feb 2022413918
Mar 2022403811
Apr 2022918912
May 2022575510
Jun 202253509
Jul 202234319
Aug 2022393711
Sep 2022444116
Oct 2022373614
Nov 2022242417
Dec 2022333321
Jan 2023474723
Feb 2023616517
Mar 2023655721
Apr 2023424111
May 2023504811
Jun 202330313
Jul 202339409
Aug 2023575129
Sep 2023454412
Oct 2023828511
Nov 2023697013
Dec 2023716515
Jan 2024373314
Feb 2024788022
Mar 20249810026
Total532851901540